The PRO-ACTIVE trial protocol: a randomized study comparing the effectiveness of PROphylACTic swallow InterVEntion for patients receiving radiotherapy for head and neck cancer.
Rosemary MartinoM I FitchC D FullerA HopeG KrisciunasS E LangmoreC LazarusC L MacdonaldT McCullochG MillsD A PalmaK PytyniaJ RingashK SultanemJ TheurerK E ThorpeK HutchesonPublished in: BMC cancer (2021)
The protocol is registered with the US Patient Centered Outcomes Research Institute, and the PRO-ACTIVE trial was prospectively registered at ClinicalTrials.gov , under the identifier NCT03455608 ; First posted: Mar 6, 2018; Last verified: Jun 17, 2021. Protocol Version: 1.3 (January 27, 2020).